Table 1.
Study | Follow-up | Sample description | N | Mean age | Personality factors examined and findings |
||||
---|---|---|---|---|---|---|---|---|---|
Axelsson et al. (2009) | Cross-sectional | Population-based sample of asthmatics | 268 | 22 | Ca | N | A | E | O |
Christensen, Moran, and Wiebe (1999) | Cross-sectional | Type I diabetics followed in endocrinology clinics | 107 | 42 | Ca | Na | |||
Dobbels et al. (2005) | Cross-sectional | Heart, lung and liver transplant candidated | 174 | 52 | Ca | N | A | E | O |
Penedo et al. (2003) | Cross-sectional | Community dwelling HIV + patients on highly active anti-retroviral therapy | 116 | 39 | C | N | A | E | O |
Christensen and Smith (1995) | 8 weeks | Renal dialysis patients at an academic centre | 72 | 46 | Ca | Na | A | E | O |
Cohen, Ross, Bagby, Farvolden, and Kenndy (2004) | 14 weeks | Depressed patients at an addiction centre | 65 | 41 | C | N | A | Ea | O |
Ediger et al. (2007) | 1 year | Population-based sample of people with inflammatory bowel disease | 326 | NR | C | N | Aa | E | O |
Insel et al. (2006) | 8 weeks | Community dwelling adults taking one or more daily medications | 60 | 77 | C | Na | A | E | O |
O’Cleirigh, Ironson, Weiss, and Costa (2007) | 1 year | Community dwelling HIV + adults | 119 | 38 | Ca | ||||
Stilley, Sereika, Muldoon, Ryan, and Dunbar-Jacob (2004) | 24 weeks | Generally healthy adults in a randomized trial of a lipid lowering drug | 158 | 46 | Ca | N | A | E | O |
Note. C, Conscientiousness; N, Neuroticism; A, agreeableness; E, Extraversion; O, Openness; HIV +, human immunodeficiency virus positive; NR, not reported.
Statistically significant association with non-adherence.